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Introduction {#sec1}
============

Electronic cigarettes (e-cigarettes), non-combustible battery-operated devices, are considered to be a safe and healthier alternative to conventional combustible cigarette smoke ([@bib4]). However, according to the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), and the National Cancer Institute analysis of the 2011--2018 National Youth Tobacco Surveys data, to estimate tobacco product use in US middle and high school students, it was reported that in 2018, the current use of any tobacco product was 27.1% in high school students (4.04 million) and 7.2% in middle school students (840,000); e-cigarettes were the most commonly used product among high school (20.8%; 3.05 million) and middle school (4.9%; 570,000) students ([@bib20]). Interestingly, e-cigarette vaping swelled by 77.8% (from 11.7% to 20.8%) among high school students and 48.5% (from 3.3% to 4.9%) among middle school students in the year 2017--2018 ([@bib20]). These figures are of great concern due to the mounting popularity of e-cigarette usage among teenagers having never smoked any combustible products.

Unlike traditional cigarettes with tobacco filling, which approximates 24 mg of nicotine per pack (1.2 mg/cigarette), e-cigarette liquid contains nicotine ([@bib7]) that varies between 6 and 48 mg/mL ([@bib7]) and is not meant to be smoked completely in one sitting ([@bib13]). Each nicotine cartridge in an e-cigarette can provide on an average 200 puffs equivalent to one to three packs of cigarettes. The nicotine absorption in the body from e-cigarette use depends on the nicotine concentration in the e-liquid, its aerosol mass quantity and deposition, the chemical form of the nicotine, as well as the vaping volume, frequency, and timing ([@bib12]). As per a 2014 report, the US FDA detected in one of the cartridges the presence of diethylene glycol, a toxic liquid used in explosives and as an antifreeze agent, in addition to, cancer-causing agents, such as tobacco-specific nitrosamines, aldehydes, metals, volatile organic compounds, phenolic compounds, polycyclic aromatic hydrocarbons, flavors, solvent carriers, tobacco alkaloids, and drugs (amino tadalafil and rimonabant) ([@bib8]). Moreover, recent studies showed that nicotine delivery and emission of some toxicant levels from the latest generation of e-cigarettes were comparable to those from tobacco smoke ([@bib11]).

The oral cavity is a gateway and a permanent or makeshift harbor for numerous microbial species to colonize the respiratory and gastrointestinal (GI) tracts ([@bib37]). The multifactorial pathogenicity of chronic periodontal disease involves a complex interaction of microbial pathogens, host immune response, and genetic and environmental factors, stimulating the host tissue destruction and bone loss ([@bib24]). Certain oral bacteria, *Porphyromonas gingivalis* and *Fusobacterium nucleatum*, are major perpetrators in periodontal destruction, highly associated with disease progression ([@bib45]). The release of host immune mediators as a primary response to these opportunistic pathogens (pathobionts) and its metabolites favors the disease state. The dysbiosis in microbial communities due to impaired homeostasis as a result of environmental and host metabolic factors can contribute to oral diseases, including dental caries, periodontitis, halitosis, or other medical ailments, such as diabetes, cardiovascular diseases, and cancers ([@bib25]). Elaborate studies have shown the toxicity of conventional tobacco product consumption to periodontal health ([@bib29]), albeit with very limited understanding on e-cigarette\'s effect ([@bib43]). The e-cigarette aerosol interaction with the host ensues largely in the oral cavity and lungs, where the exposure to nicotine and toxic metabolites of the e-liquid components is the highest and can escalate the host susceptibility to infections ([@bib8]). Recent reports associate e-cigarette vaping with vascular endothelial dysfunction causing blood-brain barrier damage with higher risk of cerebrovascular diseases ([@bib39]). Hence, it is imperative to elucidate the detrimental effect of e-liquids on the host inflammatory responses, which is highly challenging and conflicting.

The lucrative e-cigarette vaping delivery systems, available in a variety of flavors and concentrations, can pose a substantial threat to human health ([@bib20]). [@bib47] have shown that e-liquids induce inflammatory responses and alter innate immune defenses in primary airway epithelial cells. The findings of [@bib44] indicated that exposure of C57BL/6 mice to e-cigarette aerosols for 2 weeks can cause impairment of pulmonary bacterial and viral clearance. Accordingly, *in vitro* studies can be extrapolated to recognize responses by electronic nicotine delivery system users, however, without the clinical evidence of smoking history ([@bib28]). So, to understand the comprehensive health effects of vaping it is essential to conduct clinical research in conjunction with *in vitro* e-cigarette aerosol-exposed model. This will further help us to associate and understand the impact of vaping on human health by gauging the positive and negative controls.

Here, we report the *in vivo* effects of e-cigarette aerosol and its influence on human salivary microbiome and immune health. Furthermore, we evaluate *in vitro* the influence of e-cigarette aerosols on infection efficiency of oral pathogens in pre-cancerous and cancer cell lines using a novel e-cigarette aerosol-generating machine and pro-inflammatory immune mediators.

Results {#sec2}
=======

To assess the *in vivo* influence of smoking on microbial profiles of recruited participants, we stratified 119 subjects according to their smoking status into each of the three cohorts (never smokers \[NS, n = 39\], e-cigarette users \[ES, n = 40\], and regular cigarette smokers \[CS, n = 40\]). The demographic details of all the subjects and smoking history were collected at the baseline for the ES and CS groups ([Table S1](#mmc1){ref-type="supplementary-material"}). The ES and CS cohorts had a nearly equal percentage of male population (∼77%--80%). On the other hand, females were higher at 43.6% in the NS cohort. Participants exclusively using e-cigarettes vaped on an average 0.5 e-cigarettes per day, whereas participants exclusively using combustible cigarettes smoked an average of 11 cigarettes per day. There was no significant change in the salivary flow rate across the participants in different cohorts. The severity index of periodontal disease or infection was significantly higher among CS (72.5%), followed by ES (42.5%), and non-smokers (28.2%), as also reflected by the calculated mean pocket depth among cohorts. This was confirmed by the values of bleeding on probing (BoP), one of the markers for inflammation, elevated in CS and receding in e-cigarette vapers and non-smokers, although with no statistical significance. To determine the participants\' smoking status, exhaled breath carbon monoxide (CO) levels (ppm) and salivary cotinine levels (ng/mL) were evaluated. [Figures 1](#fig1){ref-type="fig"}A and 1B, respectively, illustrate the cohort-based distribution of the smoking biomarkers for CO levels in exhaled breath and salivary cotinine levels in the participants. The CO and the salivary cotinine levels were the lowest in non-smokers and the highest among traditional cigarette users ([Table S1](#mmc1){ref-type="supplementary-material"}).Figure 1Breath Carbon Monoxide and Salivary Cotinine Levels in NS, ES and CS Cohorts as a Measure of Tobacco Smoke Exposure Resulting in Skewed Bacterial Communities(A) Levels of breath carbon monoxide (ppm) across the subjects (in percentage) in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NONS): 0--6 ppm, borderline (BdL): 7--9 ppm, low addicted smoker (LAS): 10--15 ppm, moderate addicted smoker (MAS): 16--25 ppm, heavily addicted smoker (HAS): 26--35 ppm, and very heavily addicted smoker (VHAS): 36+ ppm.(B) Distribution of salivary cotinine levels in the participants of the three cohorts.(C--F) Weighted UniFrac 3D PCoA plots illustrating beta diversity of salivary bacterial taxa across all the samples. (C) Three cohorts, NS, ES, and CS (p \< 0.001); (D) between NS and ES cohorts (p = 0.005); (E) between ES and CS cohorts (p = 0.006); and (F) between NS and CS cohorts (p \< 0.001). Green, never smokers (NS); blue, e-cigarette vapers (ES); and red, cigarette smokers (CS). Ellipses indicate 95% confidence interval.

Altered Bacterial Richness and Diversity in e-Cigarette Users {#sec2.1}
-------------------------------------------------------------

The salivary microbiome in 119 participants in the NS, ES, and CS groups was analyzed using 8,254,494 high-quality filtered 16S sequences (mean 68,787 ± 19,758 SD). The salivary microbiome was composed of 11 phyla, 22 classes, 33 orders, 55 families, 99 genera, 162 species, and 911 operational taxonomic units (OTUs).

Principal coordinate analyses (PCoA) were performed to determine the overall microbiome composition in the three cohorts. Based on the weighted UniFrac distance matrix generated from all the samples in each cohort, we observed significant differences (p \< 0.05, PERMANOVA) in the microbial composition between the three cohorts ([Figure 1](#fig1){ref-type="fig"}C) and additionally, between each cohort in an independent combinatorial comparison ([Figures 1](#fig1){ref-type="fig"}D--1F). These results suggest that the microbiome structure in each of the three cohorts was distinct. Interestingly, a few of the individual ES cohort samples showed an overlap with some samples in the NS ([Figure 1](#fig1){ref-type="fig"}D) and CS ([Figure 1](#fig1){ref-type="fig"}E) cohorts, although they were significantly distinct microbiomes. These findings were reiterated by double PCoA that establishes differences in taxonomic signatures ([Figure 2](#fig2){ref-type="fig"}C) in context to breath CO levels ([Figure 2](#fig2){ref-type="fig"}A) and salivary cotinine levels ([Figure 2](#fig2){ref-type="fig"}B) of the participants.Figure 2Abundance of Microbiota with Respect to Carbon Monoxide Concentration, Cotinine Levels and Smoking Status(A--E) Double PCoA plots showing taxa correlating to the smoking status, in terms of (A) breath CO levels (in percentage), (B) cotinine levels, and (C) phyla taxonomy in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NonS): 0--6 ppm, borderline (BdL): 7--9 ppm, low addicted smoker (LaS): 10--15 ppm, moderate addicted smoker (MaS): 16--25 ppm, heavily addicted smoker (HaS): 26--35 ppm, and very heavily addicted smoker (VHaS): 36+ ppm, data not available (na). (D) Alpha diversity as measured by observed species, Shannon diversity index, and phylogenetic diversity (PD) of the salivary microbiome in NS (green), ES (blue), and CS (red) cohorts. The line inside the box represents the median, whereas the whiskers represent the lowest and highest values within the interquartile range. Outliers\' individual samples are shown as dots. Analysis was done using Mann-Whitney test. (E) Phylum-level relative abundances of the salivary microbiota based on taxonomic inference of 16S rRNA sequences. *Actinobacteria, Firmicutes, Fusobacteria, Proteobacteria,* and *Spirochaetes* were significantly altered. (D and E) Data are represented as mean ± SEM. (\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001).

The alpha diversity indices, such as observed OTUs, Shannon index, and phylogenetic diversity were computed to determine the microbial diversity within the three groups ([Figure 2](#fig2){ref-type="fig"}D). We observed a significantly higher number of observed OTUs (p = 0.023) and phylogenetic diversity (p = 0.002) in non-combustible vapers when compared with NS. No significant changes were detected in the diversity indices of the CS cohort when compared with NS and ES users. All the analysis was done using Mann-Whitney test with a confidence level of 99% (p ≤ 0.01) in each index.

Abundance of Oral Microbial Taxa in e-Cigarette Vapers {#sec2.2}
------------------------------------------------------

The relative abundance of salivary microbiome differed between non-combustible vapers and combustible smokers when compared with healthy non-smoking controls. The five most abundant taxa observed were *Firmicutes*, *Proteobacteria*, *Bacteroidetes*, *Actinobacteria*, and *Fusobacteria*, which accounted for 97.5% of the total sequences ([Figure 2](#fig2){ref-type="fig"}E). Intriguingly, *Proteobacteria* predominated the ES cohort with significantly lower levels in the CS cohort (p \< 0.0001). The CS and ES showed significantly elevated salivary *Actinobacteria* compared with NS (p \< 0.0001 and p \< 0.01, respectively). However, *Firmicutes* were highly enriched in the saliva of the CS cohort compared with those of the ES (p \< 0.01) and NS (p \< 0.0001) cohorts. On the contrary, *Fusobacteria* exhibited significant depletion in the CS cohort when compared with the ES (p \< 0.024) and NS (p \< 0.001) cohorts. Another predominant taxon, *Spirochaetes*, proliferated in the CS cohort (p \< 0.005).

The salivary microbiome in the three cohorts was significantly dominated by eight taxa; *Streptococcus*, *Veillonella*, *Prevotella*, *Neisseria*, *Haemophilus*, *Porphyromonas*, *Rothia,* and *Fusobacterium,* which constituted 79.15% of all the sequences ([Figures 3](#fig3){ref-type="fig"}A and 3B). Other differentially abundant taxa identified were *Leptotrichia*, *Gemella,* and *Capnocytophaga* ([Figures 3](#fig3){ref-type="fig"}A and 3B). A hierarchical cluster analysis showed stratification of taxa into four clusters ([Figure 3](#fig3){ref-type="fig"}C). Interestingly, the ES salivary microbiota that harbored Cluster Ib and Cluster IIb showed resemblance to those taxa distinct in NS and CS cohorts, respectively ([Figure 3](#fig3){ref-type="fig"}C). A similar pattern was also observed in the weighted PCoA plot ([Figure 1](#fig1){ref-type="fig"}C). Further analyses revealed these similarities to be closely associated with the nicotine intake (smoking status) by the ES participants. Cumulatively, the taxa observed to be proliferated were *Actinomyces* in the ES cohort, *TM7* in the ES and NS cohorts, and *Granulicatella* in the NS cohort. Moreover, *Neisseria* and *Fusobacterium* were significantly associated with the ES and NS cohorts compared with the CS cohort, p \< 0.0001, whereas the opportunistic pathogens, *Streptococcus* (p \< 0.01), *Prevotella* (p = 0.01), and *Rothia* (p = 0.002) were differentially enriched in the CS cohort. *Veillonella* levels increased significantly by ∼4% in ES (p = 0.008) and ∼4.5% (p = 0.001) in CS cohorts than NS cohorts. These findings suggest microbial dysbiosis in non-combustible vapers and combustible smokers.Figure 3Dysbiotic Salivary Bacterial Genera in NS, ES, and CS Cohorts(A) Cohort-based microbial abundances observed in NS, ES, and CS cohorts.(B) Heat tree illustrates the relationship of OTUs up to genus level. Colored branch of the tree denotes significance based on the color of individual cohorts.(C) Top 20 taxa in the saliva of the subject population across NS, ES, and CS cohorts; rectangular boxes represents two clusters where several taxa in the samples of ES cohort overlap with the samples of NS and CS cohorts.

A heat tree illustrates the relationships of species-specific OTUs in the NS, e-cigarette vapers, and CS ([Figure S1](#mmc1){ref-type="supplementary-material"}). *Streptococcus oralis subsp. tigurinus* clade 071, *Porphyromonas pasteri*, *Fusobacterium periodonticum*, and *Oribacterium parvum* were depleted significantly in the ES and CS cohorts ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). On the contrary, abundance of *Veillonella rogosae*, *Granulicatella adiacens*, and *Prevotella* sp. HMT 317 was higher in the NS cohort. *Veillonella dispar*, *Porphyromonas endodontalis*, *Fusobacterium nucleatum subsp. vincentii*, *Prevotella oris*, and *Parvimonas micra* predominated substantially in the ES and CS cohorts ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). *Veillonella atypica*, *Megasphaera micronuciformis*, *Streptococcus parasanguinis* clade 411, *Prevotella sp.* HMT 311, and *Actinomyces lingnae,* although higher in the ES cohort, significantly expanded in the CS cohort ([Figure S2](#mmc1){ref-type="supplementary-material"}C). *P. gingivalis*, *Alloprevotella tannerae*, *Dialister invisus*, *Corynebacterium durum,* and *Leptotrichia wadei* levels were proliferated in the ES cohort, whereas *Streptococcus salivarius* was higher in the CS cohort.

*In vivo* Interactions among Oral Taxa and Salivary Cytokines {#sec2.3}
-------------------------------------------------------------

To explore the salivary inflammatory markers in all participants, 39 in NS cohort and 40 in each of ES and CS cohorts, we analyzed 10 different cytokines using a human multiplex immune assay pro-inflammatory panel. Salivary interleukin (IL)-6 and IL-1β were elevated, although not significant in ES when compared with NS and CS ([Figure 4](#fig4){ref-type="fig"}A). Significant reduction in levels of interferon (IFN)-γ and IL-4 were observed in traditional CS compared with NS. Tumor necrosis factor (TNF)-α concentrations were altered significantly in non-smokers (p \< 0.05) and considerably in ES (p \< 0.1) compared with regular CS. However, other salivary cytokines showed no significant difference among cohorts. We further evaluated the association between inflammatory cytokines and salivary bacteria. Spearman correlation analysis indicated *Porphyromonas*, *Haemophilus*, *Catonella,* and *Niesseria* to be positively correlated with cytokines IL-2, IL-13, IL-8, and IL-1β ([Figure 4](#fig4){ref-type="fig"}B). In addition, *Lachnoanaerobaculum* and *Stomatobaculum* displayed positive correlation toward inflammatory immune indicators such as IL-2, IL-4, IL-8, IL-13, IL-10, IL-12p70, and IFN-γ ([Figure 4](#fig4){ref-type="fig"}B). Positive correlations were observed among *Parvimonas*, *Peptostreptococcus,* and *Mogibacterium* with IL-8 and IL-1β, and significant correlations were observed in *Fusobacterium*, *Johnsonella,* and *Catonella* with IL-1β. On the contrary, among a few taxa inverse correlation was observed, i.e., *Desulfovibrio*, *Dialister*, *Helicobacter*, *Peptostreptococcus*, *Olsenella,* and *Treponema* with TNF-α; *Bacteroides* with IL-6; *Tannerella* with TNF-α, IL-4, and IFN-γ; and *Corynebacterium* and *Olsenella* with IL-8.Figure 4Salivary Inflammatory Cytokine Expression and Its Correlation with Abundant Taxa(A and B) (A) Levels of 10 different pro-inflammatory salivary cytokines and chemokines in three cohorts, NS, ES, and CS. Data are represented as mean ± SEM. (^\#^p \< 0.1, \*p \< 0.05). (B) Correlation matrices indicate association of cytokines with the bacterial taxa. Values are represented by colors from blue (negative correlation) to red (positive correlation). Clustering is based on the Spearman rank correlation similarity between cytokines and microbial genera. (\*p \< 0.05, \*\*p \< 0.01)

To confirm and expand the relevance of the aforementioned *in vivo* findings, we next performed *in vitro* studies using the premalignant (Leuk-1) and malignant (Fadu) cell lines exposed to e-cigarette aerosols. We evaluated the altered pro-inflammatory cytokine response at mRNA and protein levels when co-cultured with the periodontal pathogens, *P. gingivalis* and *F. nucleatum*, the taxa observed to be expanded *in vivo* in the saliva of ES, and with *E. coli* GFP, one of the most established models of infection.

*In Vitro* mRNA Levels of Pro-inflammatory Cytokines Are Altered in the Presence of e-Cigarette Aerosols {#sec2.4}
--------------------------------------------------------------------------------------------------------

Fadu and Leuk-1 cells were exposed to e-cigarette aerosol or air for 40 min followed by infection with *P. gingivalis* and *F. nucleatum* for 2 h ([Figures 5](#fig5){ref-type="fig"}A and 5B). Initially, we exposed malignant Fadu cells to either air or e-cigarette aerosols followed by infection with each of these bacteria. We quantified the mRNA levels of the cytokines, IL-1β, TNF-α, IFN-γ, IL-6, and IL-8 by qPCR. A significant rise in all the five cytokine mRNA levels was detected in e-cigarette aerosol-exposed Fadu cells co-infected with *P. gingivalis* when compared with those exposed to only air co-infected with same bacteria. Intriguingly, TNF-α showed almost a 30-fold increase in expression when compared with the cells exposed only to air. Similarly, higher mRNA levels of cytokines were observed when e-cigarette aerosol-exposed Fadu cells were co-infected with *F. nucleatum.* The expansion in mRNA expression of IFN-γ was highly significant, followed by IL-6, IL-8, and IL-1β, and moderate for TNF-α upon e-cigarette aerosol exposure for Fadu cells. We further assessed the mRNA levels of TNF-α and IL-8 in the Leuk-1 cell line infected with *P. gingivalis* and *F. nucleatum* and observed results similar to that with Fadu cell line ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Significantly high mRNA expression of IL-8 was observed in e-cigarette aerosol-exposed cells with both bacteria.Figure 5mRNA Expression Levels of Various Cytokines, TNF-α, IL-8, IFN-γ, IL-1β, and IL-6 in Fadu Cells in the Presence of Bacteria and e-Cigarette Aerosols as Determined by qPCR.(A--C) Significant increase in expression of all cytokine mRNAs was observed with (A) *P. gingivalis* (B) *F. nucleatum,* and (C) *E. coli* GFP. Cells exposed to only air or e-cigarette aerosol were used as controls. Data are represented as mean ± SEM. (\*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001).

Furthermore, we examined whether a similar influence on cytokines is observed when Fadu cells were infected with the classical microbe, *E. coli* GFP ([Figure 5](#fig5){ref-type="fig"}C). Upon co-infection with this bacteria, the e-cigarette aerosol-exposed Fadu cells exhibited significantly higher mRNA levels of IL-1β and IFN-γ in contrast to air-exposed bacterial co-infected cells. In parallel, the IL-8 mRNA expression was up-regulated significantly in Fadu cells exposed to e-cigarette aerosol and *E. coli* GFP when compared with cells exposed singly to either air or e-cigarette. TNF-α, IL-8, IFN-γ, IL-1β, and IL-6 mRNA expression was also measured in Leuk-1 cells in the presence of *E. coli* GFP, and e-cigarette aerosols caused a significant rise in cytokine levels ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

The findings suggested augmented cytokine mRNA expression in Fadu as well as Leuk-1 cells upon e-cigarette aerosol exposure, and even more so when co-infected with bacteria, indicating increased susceptibility to infection in cells when exposed to e-cigarette aerosols.

e-Cigarette Aerosol Exposure Increased the Protein Levels of Pro-inflammatory Cytokines *In Vitro* {#sec2.5}
--------------------------------------------------------------------------------------------------

Fadu cells infected with *P. gingivalis*, showed significant up-regulation of IL-8 protein in the presence of e-cigarette aerosol when compared with air exposure. However, TNF-α protein levels did not significantly change in the cells infected with *P. gingivalis* and *F. nucleatum* ([Figures 6](#fig6){ref-type="fig"}A and 6B). On the contrary, under similar conditions with *F. nucleatum*, IL-8 and TNF-α protein levels were differentially up-regulated when compared with air only. However, these protein cytokine levels were not in the detectable range with *E. coli* GFP (data not shown).Figure 6Protein Cytokine Concentration of TNF-α and IL-8 in Bacteria-Treated Fadu Cell-Free Medium upon e-Cigarette Aerosol Exposure as Quantified by ELISA AssayCytokine protein levels were up-regulated with e-cigarette aerosol exposure: (A) IL-8 only with *P. gingivalis* and (B) TNF-α only with *F. nucleatum*. Data are represented as mean ± SEM. (\*p \< 0.05, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001).

In addition, when another cell line Leuk-1 was tested, up-regulated IL-8 level protein upon e-cigarette aerosol exposure was observed. Conversely, co-infection of Leuk-1 with *P. gingivalis* did not show a similar effect, where TNF-α levels were not altered ([Figure S4](#mmc1){ref-type="supplementary-material"}A). However, infection with *F. nucleatum* showed higher protein concentration of both TNF-α and IL-8 in e-cigarette aerosol-exposed cells ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Leuk-1 cells co-infected with *E.coli* GFP in the presence of e-cigarette aerosols significantly up-regulated IL-8 protein. However, the TNF-α protein levels could not be detected with ELISA due to the very low levels of expression ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

Our *in vitro* results clearly indicated that e-cigarette aerosols altered the cytokine concentration at mRNA and protein levels in the presence of periodontal pathogens, as was also confirmed with *E. coli* GFP.

e-Cigarette Aerosols Accelerate Oral Bacterial Infection {#sec2.6}
--------------------------------------------------------

To affirm that the e-cigarette aerosol influenced the rate of microbial infection *in vitro*, FaDu cells were co-cultured with either *P. gingivalis* or *F. nucleatum* pre-labeled with fluorescein isothiocyanate and then exposed to air or e-cigarette aerosol, and the infected FaDu cell population was evaluated by flow cytometry. It was observed that *P. gingivalis* and *F. nucleatum* infection in Fadu cells with e-cigarette aerosol contact increased significantly (p \< 0.05) by about 65% and 16%, respectively, compared with air only ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). Furthermore, FaDu cells were also infected with *E.coli* GFP in a 1:50 ratio after treating with either air or e-cigarette aerosol. Infection efficiency determined by GFP expression with flow cytometry showed a significant elevation (p \< 0.048) of almost 21% in FaDu cells exposed to e-cigarette aerosol than in those exposed only to air ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

Discussion {#sec3}
==========

Although e-cigarettes are conjectured to be an effective alternative to conventional cigarette smoking, statistical data insinuate an exponential rise in e-cigarette usage among college students, and its co-use with alcohol can contribute to negative consequences in the current younger generation ([@bib32]). Also, there is limited information on the effects of nicotine content in the e-cigarette on oral microbiota and periodontal infection. This study assessed the influence of different host smoking environments on periodontal health analogous to host immune response and salivary microbial profiles.

We observed that distinct microbial communities harbor the oral cavity of ES, albeit exhibiting some community overlap with either NS or conventional CS participants. Interestingly, the e-cigarette vapers that had overlapping taxa clustering with either the NS or CS cohorts presented moderate to severe periodontitis. In addition, the e-cigarette participants who shared higher abundance of certain microbial communities ([Figure 3](#fig3){ref-type="fig"}C) with the non-smoker cohort and with conventional smokers had BoP of 56.09% and 65.49%, respectively, which reflects high inflammatory fingerprint in CS participants. An earlier study has shown an association between periodontal status and the microbiota, with increased counts of several bacteria including periodonto-pathogens, *P*. *gingivalis*, *Treponema denticola*, *Tannerella forsythia,* and *Niesseria mucosa* with increased inflammatory biomarkers in the saliva of periodontal disease-positive non-smokers (n = 366) ([@bib31]). This connotes dependencies for dysbiotic microbial communes on periodontal health status, as signified by pocket depth and inflammatory responses, a measure of bleeding on probing and observed cytokine levels, in addition to salivary cotinine levels. The exposure to nicotine or other components from e-cigarette vaping expanded the abundance of periodontal pathogens. Periodontal microbes are a potential source of oral bacterial consortia that is altered by smoking, as reported earlier in the intervention studies for treatments of periodontal disease and tobacco dependence ([@bib9]).

It is well established that smoking-associated periodontitis is not just a deliberation of poor oral hygiene but extends to provide an appropriate niche for colonization of bacteria such as *P. gingivalis, Prevotella intermedia,* and *Actinobacillus actinomycetemcomitans,* facilitating development of periodontal lesions ([@bib10]). It has been reported that exposure to nicotine modulated the immunological functions via *P. gingivalis,* promoting biofilm formation by interacting with commensal oral bacteria *Streptococcus gordonii* ([@bib23]). Moreover, the salivary microbiome exemplifies bacteria from different surfaces in the oral cavity ([@bib18]). [@bib40] observed a higher prevalence of eight species, including *P. gingivalis*, in current smokers. [@bib41] showed that several bacterial complexes are involved in the etiology of periodontitis. The red complex (*P. gingivalis*, *T. forsythia*, and *T. denticola*) and orange complex (*F. nucleatum* subspecies, *F*. *periodonticum*, *Peptostreptococcus micros*, *Prevotella intermedia*, *Prevotella nigrescens*, and *Campylobacter rectus*) perio-pathogens indicate high and moderate risks, respectively, of periodontitis ([@bib41]) as detected in our study.

Moreover, we observed a significant proliferation of specific salivary taxa, to note, *Veillonella* in ES and regular CS when compared with NS. Nonetheless, *Porphyromonas* expanded significantly in ES, whereas *Prevotella* did in conventional CS. The taxon *Granulicatella* was predominant in all the three cohorts. The predominance of these periodontal pathogens in the oral cavity of ES and combustible cigarette users is a reflection of severely compromised periodontal health (p = 0.001) as depicted in [Table S1](#mmc1){ref-type="supplementary-material"}. It has been shown that nicotine and its metabolite cotinine, as well as treatment with a cigarette smoke extract, can alter the function of key periodontal pathogens such as *P. gingivalis* and promote biofilm formation, colonization, and infection ([@bib23]). *Granulicatella* is a known commensal of the human oral microbiome, however, which has been implicated in endodontic infection ([@bib38]) and is linked to increased risk of systemic diseases, such as pancreatic cancer related to oral inflammation ([@bib14]).

Cigarette smoking is known to escalate the infection risk of pathogenic or opportunistic bacteria by bringing about physiological and structural changes, increases in bacterial virulence, and immune dysfunction ([@bib3]). A sophisticated cytokine network regulates the cross talk between periodontal pathogens and immune mediators. The extent of the host inflammatory response to a microbial challenge defines the severity of periodontal disease ([@bib24]). IL-1β concentrations were found to be significantly higher along with the progression of periodontal disease ([@bib45]). *Prevotella* was found to be positively associated with the cytokine IL-1β, which suggests a high pro-inflammatory state ([@bib1]). Previous studies have indicated *Peptostreptococcus* ([@bib36]) as well as *Mogibacterium* and *Catonella* to be associated with periodontal and endodontic infections ([@bib38]). In the present study, *Veillonella* was found to be a highly abundant taxon, specifically with species *V. atypica* and *V. rogosae* being highly elevated in ES and CS cohorts. *Veillonella* are largely commensals, abundantly existing in saliva and on dorsal and lateral surfaces of the tongue ([@bib33]), and have conflicting (i.e., positive, negative, or no) associations with cigarette smoking in patients with periodontitis ([@bib27]). Previous reports suggest that *V. atypica* specifically converts ingested nitrate, largely present in the saliva of tobacco users, to nitrite, which can further be converted to potentially toxic carcinogenic nitrosamines and pro-inflammatory nitric oxide ([@bib42]). These compounds can have pathophysiological consequences on oral and systemic health. Furthermore, tobacco exposure suppresses overall immune responsiveness to bacteria and bacterial by-products such as lipopolysaccharides (LPS) ([@bib3]).

Similar to our *in vivo* results showing increased salivary IL-6 production in ES, our *in vitro* study also asserted up-regulation of IL-6 after exposure to e-cigarette aerosols in Fadu and Leuk-1 cells. Moreover, in the presence of *P. gingivalis* alone (without e-cigarette aerosols), increased IL-6 expression in Fadu and Leuk-1 cells was detected. *P. gingivalis* is known to affect leukocyte distribution near microbial colonization sites disrupting the innate host surveillance ([@bib21], [@bib26]). The observed enhanced IL-6 expression after infection with bacteria, including *P. gingivalis*, *F. nucleatum,* and *E. coli* GFP, suggests that e-cigarette aerosols enhanced susceptibility to periodontal disease. Both *P. gingivalis* and *F. nucleatum* play pivotal roles in periodontal disease and act on macrophages, neutrophils, and monocytes to induce TNF-α, IL-6, and IL-8 production ([@bib35]). TNF-α secreted by immune cells can block bone formation and inhibit collagen synthesis ([@bib16]). IL-1β synergistically acts with TNF-α in the bone resorption process, and relatively high IL-1β concentrations are reported in the gingival crevicular fluid of patients with severe periodontal disease ([@bib5]). Also, *F. nucleatum*, ubiquitous in oral cavity, is associated with chronic aggressive periodontitis, gingivitis, and endodontic infections, with additional effects such as adverse pregnancy outcomes, GI disorders, and other infections ([@bib22]). Moreover, the LPS of *F. nucleatum* stimulates improved IL-1β and TNF-α production when compared with that of *P. gingivalis* ([@bib30]). Our *in vivo* results indicated expanded IL-1β levels in the saliva of e-cigarette vapers that parallel the proliferated presence of certain periodontal pathogenic taxa, such as *Porphyromonas* and *Fusobacteria*, in this participating cohort. In addition, *F. nucleatum*, known to stimulate nuclear factor-κB-driven pro-inflammatory responses, induces colon cancer ([@bib30]). Increasing evidence revealed IL-6, IL-1β, and TNF-α involvement in dental and periodontal disease including inflamed pulp and periapical lesions ([@bib6]) and in stimulation of tissue degradation due to an increase in matrix metalloproteinases ([@bib2]). Studies have indicated high IL-6 expression at both transcriptional and translational levels in gingival mononuclear cells of patients with periodontitis ([@bib17]).

The periodontal microbes in tissues likewise stimulate chemokine IL-8 production, which induces a signal for accumulation and activation of neutrophils in local sites ([@bib46]). Importantly, IL-8 levels were expanded in Fadu cells after co-infection with *E. coli* GFP, *P. gingivalis,* or *F. nucleatum* and increased maximally in cells treated with bacteria and exposed to e-cigarette aerosols. Also, our results have shown an up-regulation of IFN-γ upon co-incubation with e-cigarette aerosols and *E. coli GFP* when compared with air only, e-cigarette only, and combination of air and bacteria. IFN-γ is a key player in immune responses in periodontal disease ([@bib19]) and in the activation of immunomodulation in mesenchymal stem cells. *In vivo* studies reported that mice, in the absence of IFN-γ, showed decreased bone loss after *P. gingivalis* infection in oral cavity ([@bib34]). The limitations of this experimental design are that all *in vitro* experiments were done on cell culture models using oral pathogens, and it will be valuable to include primary cell or 3D oral tissue models and other canonical intracellular pathogen (e.g., *Listeria*) in our future experiments.

The presented data suggest that vaping e-cigarettes causes oral environmental shifts and highly influences the colonization of complex heterogeneous microbial biofilms. More elaborate studies would help in identifying the detrimental effects of e-cigarette aerosols and its toxic components, albeit taking into consideration other confounding factors such as vaping behavior and the dual use of e-cigarettes and conventional cigarettes. With the advent of more advanced versions of e-cigarettes, users have greater control over the quantity of e-liquid usage, power, and airflow settings. In one study, higher plasma nicotine levels were detected in newer generation of e-cigarettes compared with a first-generation e-cigarette device ([@bib15]). Studies are also warranted to evaluate the long-term adverse effects of metal fumes and other contaminants associated with e-cigarette usage. As e-cigarettes have become commercially available only in the past 10--12 years, there is no study that assesses the long-term health hazards associated with their use. However, very recently, the CDC and FDA reported about 215 cases of mysterious lung illnesses, linked to e-cigarette usage and vaping among teens and young adults in 25 states, currently under investigation with state and federal health officials (<https://www.cdc.gov/media/releases/2019/s0830-statement-e-cigarette.html>, August 30, 2019). Consequently, detailed studies will help to elucidate the mechanism and pathways of host-microbe interactions when in contact with e-cigarette aerosols that could compromise oral, respiratory, and cardiovascular health and its implication in DNA damage with cancer as a potential consequence.

Limitations of the Study {#sec4}
========================

The limitations of this experimental design are that all *in vitro* experiments were done on cell culture models using oral pathogens, and it will be valuable to include primary cell or 3D oral tissue models. We have used three bacteria to study the increase in infection after aerosol exposure; however, it will be helpful if other canonical intracellular pathogens (e.g., *Listeria*) are used in future experiments.

Methods {#sec5}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S5, and Table S1
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